What are the major opportunities in the Neurogenetic Testing market? What are the strategies for the Neurogenetic Testing market?

For detailed insights on the major opportunities and strategies in the Neurogenetic Testing market, Read More

How does the Neurogenetic Testing market relate to the overall economy and other similar markets?

For detailed insights on Neurogenetic Testing's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Neurogenetic Testing industry?

For detailed insights on the mergers and acquisitions in the Neurogenetic Testing industry, Read More

What are the key dynamics influencing the Neurogenetic Testing market growth? SWOT analysis of the Neurogenetic Testing market.

For detailed insights on the key dynamics influencing the Neurogenetic Testing market growth and SWOT analysis of the Neurogenetic Testing industry, Read More

Neurogenetic Testing Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Neurogenetic Testing Market Report 2026

Name: Neurogenetic Testing Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Microarray Analysis, Whole-Exome Sequencing (WES), Multiplex Ligation Dependent Probe Amplification (MLPA), Polymerase Chain Reaction (PCR) Tests, Other Types), By Disease (Rare Genetic Disorder, Huntington’s Disease, Fragile X Syndrome, Other Diseases), By End-Users (Hospitals, Specialty Clinics, Research Institutes, Diagnostics Laboratories) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Neurogenetic Testing Market Overview

• Neurogenetic Testing market size has reached to $0.7 billion in 2025

• Expected to grow to $1.24 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%

• Growth Driver: Rising Prevalence Of Neurological Disorders Fuels Demand For Neurogenetic Testing

• Market Trend: Innovative Products Driving Growth In The Neurogenetic Testing Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neurogenetic Testing Market?

Neurogenetic testing is a type of genetic testing that focuses on identifying genetic variations associated with neurological disorders or conditions affecting the nervous system. It is used for diagnosing, predicting, and managing neurological disorders, as well as facilitating research and the development of personalized treatment approaches in the field of neurology and genetics.

The main types of neurogenetic testing market are microarray analysis, whole-exome sequencing (WES), multiplex ligation dependent probe amplification (MLPA), polymerase chain reaction (PCR) tests, and other types. Microarray analysis is a technique used in neurogenetic testing to simultaneously analyze the expression levels of thousands of genes. The various diseases are rare genetic disorder, cancer, cystic fibrosis, sickle cell anemia, duchenne muscular dystrophy, thalassemia, huntington’s disease, fragile x syndrome, and other diseases involved by various end-users such as hospitals, specialty clinics, research institutes, and diagnostics laboratories.

Neurogenetic Testing Market Global Report 2026 Market Report bar graph

What Is The Neurogenetic Testing Market Size and Share 2026?

The neurogenetic testing market size has grown rapidly in recent years. It will grow from $0.7 billion in 2025 to $0.79 billion in 2026 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to early adoption of pcr-based genetic testing, rising prevalence of inherited neurological disorders, increased use of microarray platforms, development of early diagnostic techniques, initial integration of genetic screening into clinical workflows.

What Is The Neurogenetic Testing Market Growth Forecast?

The neurogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $1.24 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to growing demand for next-generation sequencing, increasing expansion of clinical exome sequencing, rising investment in genetic research, development of advanced molecular diagnostic tools, growing adoption of personalized neurological treatment approaches. Major trends in the forecast period include rising adoption of whole-exome sequencing technologies, increasing use of pcr-based neurological genetic tests, growing implementation of microarray analysis, expansion of testing for rare neurological genetic disorders, growing demand for early diagnosis and predictive testing.

Book your 30 minutes free consultation with our research experts

Global Neurogenetic Testing Market Segmentation

1) By Type: Microarray Analysis, Whole-Exome Sequencing (WES), Multiplex Ligation Dependent Probe Amplification (MLPA), Polymerase Chain Reaction (PCR) Tests, Other Types

2) By Disease: Rare Genetic Disorder, Huntington’s Disease, Fragile X Syndrome, Other Diseases

3) By End-Users: Hospitals, Specialty Clinics, Research Institutes, Diagnostics Laboratories

Subsegments:

1) By Microarray Analysis: Comparative Genomic Hybridization (CGH) Microarray, Single Nucleotide Polymorphism (SNP) Microarray, Gene Expression Microarray

2) By Whole-Exome Sequencing (WES): Targeted Exome Sequencing, Clinical Exome Sequencing, Research-Grade Exome Sequencing

3) By Multiplex Ligation Dependent Probe Amplification (MLPA): MLPA For Copy Number Variation, MLPA For Methylation Analysis, MLPA For Specific Disease Detection

4) By Polymerase Chain Reaction (PCR) Tests: Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR (dPCR)

5) By Other Types: Next-Generation Sequencing (NGS), Southern Blotting, Fluorescence In Situ Hybridization (FISH), Sanger Sequencing

What Are The Drivers Of The Neurogenetic Testing Market?

The rising prevalence of neurological disorders is expected to propel the growth of the neurogenetic testing market. Neurological disorders refer to any conditions that affect the nervous system, which includes the brain, spinal cord, and nerves. The prevalence of neurological disorders are the cause of genetic predisposition, infections, trauma, toxins, autoimmune responses, and degeneration. Neurogenetic testing significantly enhances the diagnosis, treatment, and management of neurological disorders by offering personalized insights into genetic risk factors, guiding treatment decisions, and empowering individuals and families to make informed healthcare choices, thereby improving patient care and outcomes. For instance, in October 2023, according to the World Federation of Neurology, a UK-based charity, reflecting an accelerating global health burden, neurological disorders now represent the second-leading cause of death and the primary cause of disability worldwide, with more than 40 percent of the global population affected in 2023 and the number of individuals living with brain disease projected to nearly double by 2050. Therefore, the rising prevalence of neurological disorders is expected to drive the growth of the neurogenetic testing industry.

The rising prevalence of cancer is expected to propel the growth of the neurogenetic testing market. Cancer refers to a disease in which abnormal cells divide uncontrollably and destroy body tissue. Cancer cases are increasing due to several factors, including the obesity epidemic, inherited genetic abnormalities, hepatitis B and C viruses, Epstein-Barr virus (EBV), and human papillomavirus (HPV). Neurogenetic testing is essential to the management of cancer, as it assists in choosing the most effective course of treatment, evaluates prognoses, identifies high-risk patients, and provides individualized care based on the particular genetic profile and family history of each patient. For instance, in January 2024, according to the data published by the American Cancer Society, a US-based non-profit organization, the United States is projected to see 2,001,140 new cancer cases and 611,720 cancer deaths in 2024, compared to 1,958,310 cases and 609,820 deaths in 2023. Therefore, the rising prevalence of cancer is driving the growth of the neurogenetic testing industry.

Key Players In The Global Neurogenetic Testing Market

Major companies operating in the neurogenetic testing market are Thermo Fisher Scientific Inc., Mayo Clinic, Roche Diagnostics Corporation, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., BioReference Laboratories Inc., Connecticut Children’s, Invitae Corp., Ambry Genetics Corporation, Fulgent Genetics Inc., Blueprint Genetics Inc., GeneDx LLC, Pacific Biosciences of California Inc., MedGenome Labs, CENTOGENE, Baylor Genetics, Victorian Clinical Genetics Services

Global Neurogenetic Testing Market Trends and Insights

Major companies operating in the neurogenetic testing market are developing innovative products, such as whole-genome sequencing, to enhance the accuracy and scope of genetic analysis, enabling more comprehensive and personalized testing for neurological disorders. Whole-genome sequencing (WGS) is a comprehensive genetic testing method that involves determining the complete DNA sequence of an individual's entire genome. For instance, in March 2024, Nucleus Genomics, a US-based company that provides genetic analysis, launched a DNA analysis product. Through this platform empower people with a deeper understanding of their genetic predispositions, facilitating informed decisions about their health and well-being. With cutting-edge technology and expert genetic counseling services, Nucleus Genomics is set to redefine the landscape of genetic testing, bringing the power of whole-genome sequencing directly into the hands of individuals and revolutionizing the field of genomic medicine.

Need data on a specific region in this market?

Request Regional Data

Regional Outlook

North America was the largest region in the neurogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neurogenetic Testing Market?

The neurogenetic testing market includes revenues earned by entities by providing services such as diagnostic testing, predictive testing, carrier screening, and prenatal testing and related products such as genetic testing kits, DNA sequencing platforms, and bioinformatics software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neurogenetic Testing Market Report 2026?

The neurogenetic testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neurogenetic testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neurogenetic Testing Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$0.79 billion
Revenue Forecast In 2035	$1.24 billion
Growth Rate	CAGR of 13.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Disease, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Thermo Fisher Scientific Inc., Mayo Clinic, Roche Diagnostics Corporation, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., BioReference Laboratories Inc., Connecticut Children’s, Invitae Corp., Ambry Genetics Corporation, Fulgent Genetics Inc., Blueprint Genetics Inc., GeneDx LLC, Pacific Biosciences of California Inc., MedGenome Labs, CENTOGENE, Baylor Genetics, Victorian Clinical Genetics Services
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neurogenetic Testing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neurogenetic Testing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neurogenetic Testing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neurogenetic Testing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.2. Major Trends

4.2.1 Rising Adoption Of Whole-Exome Sequencing Technologies

4.2.2 Increasing Use Of Pcr-Based Neurological Genetic Tests

4.2.3 Growing Implementation Of Microarray Analysis

4.2.4 Expansion Of Testing For Rare Neurological Genetic Disorders

4.2.5 Growing Demand For Early Diagnosis And Predictive Testing

5. Neurogenetic Testing Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Research Institutes

5.4 Diagnostic Laboratories

5.5 Genetic Testing Centers

6. Neurogenetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neurogenetic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neurogenetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neurogenetic Testing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neurogenetic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neurogenetic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neurogenetic Testing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neurogenetic Testing Market Segmentation

9.1. Global Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Microarray Analysis, Whole-Exome Sequencing (WES), Multiplex Ligation Dependent Probe Amplification (MLPA), Polymerase Chain Reaction (PCR) Tests, Other Types

9.2. Global Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rare Genetic Disorder, Huntington’s Disease, Fragile X Syndrome, Other Diseases

9.3. Global Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Research Institutes, Diagnostics Laboratories

9.4. Global Neurogenetic Testing Market, Sub-Segmentation Of Microarray Analysis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Comparative Genomic Hybridization (CGH) Microarray, Single Nucleotide Polymorphism (SNP) Microarray, Gene Expression Microarray

9.5. Global Neurogenetic Testing Market, Sub-Segmentation Of Whole-Exome Sequencing (WES), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Targeted Exome Sequencing, Clinical Exome Sequencing, Research-Grade Exome Sequencing

9.6. Global Neurogenetic Testing Market, Sub-Segmentation Of Multiplex Ligation Dependent Probe Amplification (MLPA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

MLPA For Copy Number Variation, MLPA For Methylation Analysis, MLPA For Specific Disease Detection

9.7. Global Neurogenetic Testing Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR) Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR (dPCR)

9.8. Global Neurogenetic Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Next-Generation Sequencing (NGS), Southern Blotting, Fluorescence In Situ Hybridization (FISH), Sanger Sequencing

10. Neurogenetic Testing Market Regional And Country Analysis

10.1. Global Neurogenetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neurogenetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neurogenetic Testing Market

11.1. Asia-Pacific Neurogenetic Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neurogenetic Testing Market

12.1. China Neurogenetic Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neurogenetic Testing Market

13.1. India Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neurogenetic Testing Market

14.1. Japan Neurogenetic Testing Market Overview

14.2. Japan Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neurogenetic Testing Market

15.1. Australia Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neurogenetic Testing Market

16.1. Indonesia Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neurogenetic Testing Market

17.1. South Korea Neurogenetic Testing Market Overview

17.2. South Korea Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neurogenetic Testing Market

18.1. Taiwan Neurogenetic Testing Market Overview

18.2. Taiwan Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neurogenetic Testing Market

19.1. South East Asia Neurogenetic Testing Market Overview

19.2. South East Asia Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neurogenetic Testing Market

20.1. Western Europe Neurogenetic Testing Market Overview

20.2. Western Europe Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neurogenetic Testing Market

21.1. UK Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neurogenetic Testing Market

22.1. Germany Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neurogenetic Testing Market

23.1. France Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neurogenetic Testing Market

24.1. Italy Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neurogenetic Testing Market

25.1. Spain Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neurogenetic Testing Market

26.1. Eastern Europe Neurogenetic Testing Market Overview

26.2. Eastern Europe Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neurogenetic Testing Market

27.1. Russia Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neurogenetic Testing Market

28.1. North America Neurogenetic Testing Market Overview

28.2. North America Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neurogenetic Testing Market

29.1. USA Neurogenetic Testing Market Overview

29.2. USA Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neurogenetic Testing Market

30.1. Canada Neurogenetic Testing Market Overview

30.2. Canada Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neurogenetic Testing Market

31.1. South America Neurogenetic Testing Market Overview

31.2. South America Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neurogenetic Testing Market

32.1. Brazil Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neurogenetic Testing Market

33.1. Middle East Neurogenetic Testing Market Overview

33.2. Middle East Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neurogenetic Testing Market

34.1. Africa Neurogenetic Testing Market Overview

34.2. Africa Neurogenetic Testing Market, Segmentation By Type, Segmentation By Disease, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neurogenetic Testing Market Regulatory and Investment Landscape

36. Neurogenetic Testing Market Competitive Landscape And Company Profiles

36.1. Neurogenetic Testing Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neurogenetic Testing Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neurogenetic Testing Market Company Profiles

36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

37. Neurogenetic Testing Market Other Major And Innovative Companies

Eurofins Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., BioReference Laboratories Inc., Connecticut Children’s, Invitae Corp., Ambry Genetics Corporation, Fulgent Genetics Inc., Blueprint Genetics Inc., GeneDx LLC, Pacific Biosciences of California Inc.

38. Global Neurogenetic Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neurogenetic Testing Market

40. Neurogenetic Testing Market High Potential Countries, Segments and Strategies

40.1 Neurogenetic Testing Market In 2030 - Countries Offering Most New Opportunities

40.2 Neurogenetic Testing Market In 2030 - Segments Offering Most New Opportunities

40.3 Neurogenetic Testing Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Neurogenetic Testing Market, Overview Of Key Products - Product Examples

Table 2: Global Neurogenetic Testing Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Neurogenetic Testing Market, Supply Chain Analysis

Table 4: Global Neurogenetic Testing Market, Major Raw Material Providers

Table 5: Global Neurogenetic Testing Market, Major Resource Providers

Table 6: Global Neurogenetic Testing Market, Major Manufacturers (Suppliers)

Table 7: Global Neurogenetic Testing Market, Major Distributors And Channel Partners

Table 8: Global Neurogenetic Testing Market, Key Technologies & Future Trends

Table 9: Global Neurogenetic Testing Market, Major Trends

Table 10: Global Neurogenetic Testing Market, Major End Users

Table 11: Global Neurogenetic Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Neurogenetic Testing Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Neurogenetic Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Neurogenetic Testing Market - TAM, US$ Billion, 2025

Table 15: Global Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Neurogenetic Testing Market, Sub-Segmentation Of Microarray Analysis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Neurogenetic Testing Market, Sub-Segmentation Of Whole-Exome Sequencing (WES), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Neurogenetic Testing Market, Sub-Segmentation Of Multiplex Ligation Dependent Probe Amplification (MLPA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Neurogenetic Testing Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR) Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Neurogenetic Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Neurogenetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Neurogenetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Neurogenetic Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Neurogenetic Testing Market - Company Scoring Matrix

Table 99: Thermo Fisher Scientific Inc. Financial Performance

Table 100: Mayo Clinic Financial Performance

Table 101: Roche Diagnostics Corporation Financial Performance

Table 102: Laboratory Corporation Financial Performance

Table 103: Quest Diagnostics Incorporated Financial Performance

Table 104: Global Neurogenetic Testing Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Neurogenetic Testing Market, Competitive Dashboard

Table 106: Global Neurogenetic Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Neurogenetic Testing Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 108: Global, Neurogenetic Testing Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Table 109: Global, Neurogenetic Testing Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

List Of Figures

Figure 1: Global Neurogenetic Testing Market, Overview Of Key Products - Product Examples

Figure 2: Global Neurogenetic Testing Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Neurogenetic Testing Market, Supply Chain Analysis

Figure 4: Global Neurogenetic Testing Market, Major Raw Material Providers

Figure 5: Global Neurogenetic Testing Market, Major Resource Providers

Figure 6: Global Neurogenetic Testing Market, Major Manufacturers (Suppliers)

Figure 7: Global Neurogenetic Testing Market, Major Distributors And Channel Partners

Figure 8: Global Neurogenetic Testing Market, Key Technologies & Future Trends

Figure 9: Global Neurogenetic Testing Market, Major Trends

Figure 10: Global Neurogenetic Testing Market, Major End Users

Figure 11: Global Neurogenetic Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Neurogenetic Testing Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Neurogenetic Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Neurogenetic Testing Market - TAM, US$ Billion, 2025

Figure 15: Global Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Neurogenetic Testing Market, Sub-Segmentation Of Microarray Analysis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Neurogenetic Testing Market, Sub-Segmentation Of Whole-Exome Sequencing (WES), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Neurogenetic Testing Market, Sub-Segmentation Of Multiplex Ligation Dependent Probe Amplification (MLPA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Neurogenetic Testing Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR) Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Neurogenetic Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Neurogenetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Neurogenetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Neurogenetic Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Neurogenetic Testing Market - Company Scoring Matrix

Figure 99: Thermo Fisher Scientific Inc. Financial Performance

Figure 100: Mayo Clinic Financial Performance

Figure 101: Roche Diagnostics Corporation Financial Performance

Figure 102: Laboratory Corporation Financial Performance

Figure 103: Quest Diagnostics Incorporated Financial Performance

Figure 104: Global Neurogenetic Testing Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Neurogenetic Testing Market, Competitive Dashboard

Figure 106: Global Neurogenetic Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Neurogenetic Testing Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 108: Global, Neurogenetic Testing Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Figure 109: Global, Neurogenetic Testing Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Global Outpatient Clinics Market Forecast to Reach $53.81 Billion by 2029, Driven by 5.3% CAGR

Outpatient Home Therapy Industry Poised for Rapid Expansion, Projected to Hit $72.97 Billion by 2029

In-Depth Outpatient Oncology Infusion Market Report: Business Trends, Growth Factors, and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

In-App Purchase Market Report 2026 - Global Outlook – By Type (Consumable, Non-Consumable, Subscription), By Operating System (Android, iOS, Other Operating Systems), By App Category (Gaming, Entertainment And Music, Hea...

Dental Veneers Market Report 2026 - Global Outlook – By Product (Porcelain Veneers, Composite Veneers, Other Products), By Application (Cosmetic, Medical), By End Users (Hospitals, Dental Clinics, Other End Users) – Mark...

Vegan Ice Cream Market Report 2026 - Global Outlook – By Source (Coconut Milk, Almond Milk, Cashew Milk, Soy Milk), By Product (Impulse, Artisanal, Take Home), By Form (Singles, Blends), By Flavor (Vanilla, Chocolate, Bu...

Advance Directives Market Report 2026 - Global Outlook – By Component (Software, Services), By Demographics (Elderly Population (More Than 65 years), Middle Aged (40 To 64 years), Young Adults (18 To 39 years)), By End U...

Fruit Puree Market Report 2026 - Global Outlook – By Fruit Type (Apple Puree, Banana Puree, Plum Puree, Strawberry Puree, Other Fruit Types), By Category (Organic, Conventional), By Application (Beverages, Bakery, Baby F...

Magnesium Oxide Nanopowder Market Report 2026 - Global Outlook – By Type (99% Magnesium Oxide Nanopowder, 99.9% Magnesium Oxide Nanopowder, 99.99% Magnesium Oxide Nanopowder, 99.999% Magnesium Oxide Nanopowder), By Appli...

Animal Based Protein Supplements Market Report 2026 - Global Outlook – By Product (Protein Powder, Protein Bars, Ready-To-Drink, Other Products), By Raw Materials (Whey, Casein, Egg, Fish, Other Raw Materials), By Applic...

Frequently Asked Questions

How big is the Neurogenetic Testing Market?

The Neurogenetic Testing market was valued at $0.7 billion in 2025, increased to $0.79 billion in 2026, and is projected to reach $1.24 billion by 2030.

What is the Neurogenetic Testing market growth?

The global Neurogenetic Testing market is expected to grow at a CAGR of 11.9% from 2026 to 2035 to reach $1.24 billion by 2035.

Who are the key players in Neurogenetic Testing market?

Some Key Players in the Neurogenetic Testing market Include, Thermo Fisher Scientific Inc., Mayo Clinic, Roche Diagnostics Corporation, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific Inc., Agilent Technologies Inc., Perkin

Major trend in this market includes: Innovative Products Driving Growth In The Neurogenetic Testing Market. For further insights on this market. request a sample here

North America was the largest region in the neurogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurogenetic testing market report are Asia-Pacific

Book your 30 minutes free consultation with our research experts

Contact Us